Literature DB >> 7349901

An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture.

J S Whitehead, Y S Kim.   

Abstract

The culture fluid taken from a human colonic adenocarcinoma cell line, SKCO-1, inhibited mitogenic stimulation of mouse lymphocytes measured by reductions in blast information or [3H]thymidine uptake. The inhibitor was not cytotoxic to lymphocytes nor did it alter the growth rates of 21 other cell lines examined. However, the in vitro growth rates of two murine lymphoid tumor lines were also markedly reduced by the SKCO-1 medium. The tumor cell culture media could be added up to 40 hr after concanavalin A stimulation and still effect complete inhibition of [3H]thymidine uptake. A similar inhibition was observed for phytohemagglutinin (from red kidney bean), lipopolysaccharide, and mixed lymphocyte response assays. The inhibitor has a molecular weight of greater than 100,000 and is stable to heat and ultraviolet radiation, but is destroyed by mild periodate oxidation. The inhibitor may play a role in immunosuppression.

Entities:  

Mesh:

Year:  1980        PMID: 7349901

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro.

Authors:  P J Guillou; P C Sedman; C W Ramsden
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells.

Authors:  A Keong; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Inhibitors of lymphocyte activation secreted by human melanoma cell lines.

Authors:  D Giacomoni; S Ben-Efraim; F Najmabadi; S Dray
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

5.  In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.

Authors:  G J Pommier; F L Garrouste; D Bettetini; J M Culouscou; M M Remacle-Bonnet
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.

Authors:  L Håkansson; G Adell; B Boeryd; F Sjögren; R Sjödahl
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.